<p>Arbejdsmarkedets Tillaegspension 在最近向证券交易委员会的披露中表示，在第四季度购买了 Medtronic PLC（纽约证券交易所代码：MDT - 免费报告）的新股份。该基金购买了 233,477 股这家医疗技术公司的股票，价值约为 22,428,000 美元。</p>
<ul>
<li>分析师喜爱 DexCom 的 3 个理由</li>
</ul>
<p>其他一些大型投资者最近也买卖了该公司的股票。Brighton Jones LLC 在第四季度将其在 Medtronic 的持股比例提高了 1,368.0%。Brighton Jones LLC 现在拥有 39,989 股这家医疗技术公司的股票，价值 3,194,000 美元，此前在该期间内又购买了 37,265 股。Sivia Capital Partners LLC 在第二季度将其在 Medtronic 的持股比例提高了 9.6%。Sivia Capital Partners LLC 现在拥有 4,356 股这家医疗技术公司的股票，价值 380,000 美元，此前在上个季度又购买了 381 股。Jump Financial LLC 在第二季度购买了 Medtronic 的新股份，价值约为 299,000 美元。Main Street Financial Solutions LLC 在第二季度将其在 Medtronic 的持股比例提高了 28.9%。Main Street Financial Solutions LLC 现在拥有 14,356 股这家医疗技术公司的股票，价值 1,251,000 美元，此前在上个季度又购买了 3,218 股。最后，HUB Investment Partners LLC 在第二季度将其在 Medtronic 的持股比例提高了 21.3%。HUB Investment Partners LLC 现在拥有 19,226 股这家医疗技术公司的股票，价值 1,676,000 美元，此前在该期间内又购买了 3,376 股。82.06% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>Medtronic 股价表现</h2>
<p>MDT 股票在周五开盘价为 76.12 美元。该公司的市值为 977.3 亿美元，市盈率为 21.20，市盈增长比率为 1.83，贝塔值为 0.62。Medtronic PLC 的 12 个月低点为 74.40 美元，12 个月高点为 106.33 美元。该公司的 50 日简单移动平均线为 84.76 美元，200 日简单移动平均线为 93.64 美元。该公司的流动比率为 2.54，速动比率为 1.87，债务与股本比率为 0.57。</p>
<ul>
<li>Intuitive Surgical 的抛售为 30% 的反弹机会铺平道路</li>
</ul>
<p>Medtronic（纽约证券交易所代码：MDT - 获取免费报告）最近于 2 月 17 日星期二发布了季度财报。这家医疗技术公司报告本季度每股收益为 1.36 美元，超出市场共识预期的 1.34 美元 0.02 美元。Medtronic 的股本回报率为 14.82%，净利润率为 13.00%。该公司本季度的收入为 90.2 亿美元，而分析师预期为 88.9 亿美元。在去年同期，该公司每股收益为 1.38 美元。与去年同期相比，该公司的季度收入增长了 5.8%。Medtronic 将其 2026 财年的指引设定为每股收益 5.620-5.660。整体来看，股票分析师预计 Medtronic PLC 今年将发布每股收益 5.57。</p>
<h2>Medtronic 宣布分红</h2>
<p>该公司还最近披露了季度分红，已于 4 月 17 日星期五支付。3 月 27 日的股东获得了 0.71 美元的分红。除息日期为 3 月 27 日。这代表着每年 2.84 美元的分红，收益率为 3.7%。Medtronic 的分红支付比率目前为 79.11%。</p>
<h2>分析师升级和降级</h2>
<ul>
<li>5 只可能在 2026 年回报耐心投资者的分拆股票</li>
</ul>
<p>几位分析师最近对该股票发布了报告。摩根大通将 Medtronic 的目标价从 105.00 美元下调至 100.00 美元，并在 2 月 18 日的报告中对该股票给予了 “中性” 评级。Weiss Ratings 将 Medtronic 的评级从 “买入（b-）” 下调至 “持有（c+）”，在 4 月 21 日的研究报告中。Jefferies Financial Group 重申了 “持有” 评级，并在 4 月 23 日的研究报告中将 Medtronic 的目标价设定为 95.00 美元。Needham &amp; Company LLC 重申了 “买入” 评级，并在 3 月 26 日的研究报告中将 Medtronic 的目标价设定为 120.00 美元。最后，中金公司在 1 月 30 日的研究报告中对 Medtronic 开展了覆盖，给予了该股票 “跑赢大盘” 的评级。十五位投资分析师对该股票给予了买入评级，十一位给予了持有评级。根据 MarketBeat，该股票的平均评级为 “适度买入”，平均目标价为 107.80 美元。</p>
<p><strong>查看我们对 MDT 的最新分析</strong></p>
<h2>Medtronic 的内部交易</h2>
<p>在其他 Medtronic 的新闻中，执行副总裁 Harry Skip Kiil 于 2 月 19 日星期四出售了 52,524 股该公司的股票。股票以平均价格 97.71 美元出售，总价值为 5,132,120.04 美元。出售后，该执行副总裁持有 32,768 股该公司的股票，价值约为 3,201,761.28 美元。这代表着他们持有的股票减少了 61.58%。该交易已在向证券交易委员会提交的文件中披露，文件可通过 SEC 网站访问。内部人士持有该公司 0.26% 的股票。</p>
<h2>Medtronic 公司简介</h2>
<p>（免费报告）</p>
<p>Medtronic plc 是一家全球医疗技术公司，开发和制造广泛的治疗设备和医疗保健解决方案。公司合法总部位于爱尔兰，主要运营办公室位于美国，向全球医院、医生和医疗系统销售产品，自 1949 年成立以来，已发展成为服务全球医疗市场的最大医疗设备制造商之一。</p>
<p>美敦力的产品涵盖多个临床领域，包括心脏节律和心力衰竭（心脏起搏器、植入式心脏复律除颤器及相关心脏治疗）、微创和外科技术（腹腔镜和先进能量设备、可视化系统及外科创新）、修复治疗（脊柱和骨科、神经调节和神经血管治疗）以及糖尿病管理（胰岛素输送系统和血糖监测解决方案）。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们认为比美敦力更好的股票</li>
<li>维京航运创下历史新高——基本面信号显示未来还有更多</li>
<li>Datavalut 获得关注：现在卖出的五个理由</li>
<li>TMC 股票：为什么这家无收入矿业公司值得关注</li>
<li>电网正在衰退——是时候购买其替代品了吗？</li>
</ul>
<p><strong>想看看其他对美敦力持有股份的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取美敦力 PLC（NYSE:MDT - 免费报告）的最新 13F 文件和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在美敦力吗？</h2>
<p>在考虑美敦力之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而美敦力并不在名单上。</p>
<p>虽然美敦力目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

美敦力

美国医药设备 ETF - iShares

医药突破 ETF - ALPS

<p>Arbejdsmarkedets Tillaegspension 在美敦力（Medtronic PLC）中获得了新的股份，购买了 233,477 股，价值约 2240 万美元。其他投资者也增加了在美敦力的持仓。该公司报告的季度每股收益为 1.36 美元，超出预期，收入为 90.2 亿美元。美敦力宣布季度股息为 0.71 美元，收益率为 3.7%。分析师对该股票的评级不一，平均目标价为 107.80 美元</p>

<p>Arbejdsmarkedets Tillaegspension bought a new stake in shares of Medtronic PLC (NYSE:MDT - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 233,477 shares of the medical technology company's stock, valued at approximately $22,428,000.</p>
<div class="lb-trans"><p>Arbejdsmarkedets Tillaegspension 在最近向证券交易委员会的披露中表示，在第四季度购买了 Medtronic PLC（纽约证券交易所代码：MDT - 免费报告）的新股份。该基金购买了 233,477 股这家医疗技术公司的股票，价值约为 22,428,000 美元。</p>
</div><ul>
<li>3 Reasons Analysts Love DexCom</li>
</ul>
<div class="lb-trans"><ul>
<li>分析师喜爱 DexCom 的 3 个理由</li>
</ul>
</div><p>A number of other large investors also recently bought and sold shares of the business. Brighton Jones LLC boosted its position in shares of Medtronic by 1,368.0% in the fourth quarter. Brighton Jones LLC now owns 39,989 shares of the medical technology company's stock worth $3,194,000 after purchasing an additional 37,265 shares during the period. Sivia Capital Partners LLC raised its position in shares of Medtronic by 9.6% in the 2nd quarter. Sivia Capital Partners LLC now owns 4,356 shares of the medical technology company's stock valued at $380,000 after purchasing an additional 381 shares during the last quarter. Jump Financial LLC purchased a new position in Medtronic during the 2nd quarter worth approximately $299,000. Main Street Financial Solutions LLC increased its holdings in shares of Medtronic by 28.9% during the 2nd quarter. Main Street Financial Solutions LLC now owns 14,356 shares of the medical technology company's stock valued at $1,251,000 after purchasing an additional 3,218 shares in the last quarter. Finally, HUB Investment Partners LLC grew its stake in Medtronic by 21.3% in the 2nd quarter. HUB Investment Partners LLC now owns 19,226 shares of the medical technology company's stock valued at $1,676,000 after acquiring an additional 3,376 shares during the period. 82.06% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>其他一些大型投资者最近也买卖了该公司的股票。Brighton Jones LLC 在第四季度将其在 Medtronic 的持股比例提高了 1,368.0%。Brighton Jones LLC 现在拥有 39,989 股这家医疗技术公司的股票，价值 3,194,000 美元，此前在该期间内又购买了 37,265 股。Sivia Capital Partners LLC 在第二季度将其在 Medtronic 的持股比例提高了 9.6%。Sivia Capital Partners LLC 现在拥有 4,356 股这家医疗技术公司的股票，价值 380,000 美元，此前在上个季度又购买了 381 股。Jump Financial LLC 在第二季度购买了 Medtronic 的新股份，价值约为 299,000 美元。Main Street Financial Solutions LLC 在第二季度将其在 Medtronic 的持股比例提高了 28.9%。Main Street Financial Solutions LLC 现在拥有 14,356 股这家医疗技术公司的股票，价值 1,251,000 美元，此前在上个季度又购买了 3,218 股。最后，HUB Investment Partners LLC 在第二季度将其在 Medtronic 的持股比例提高了 21.3%。HUB Investment Partners LLC 现在拥有 19,226 股这家医疗技术公司的股票，价值 1,676,000 美元，此前在该期间内又购买了 3,376 股。82.06% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>Medtronic Price Performance</h2>
<div class="lb-trans"><h2>Medtronic 股价表现</h2>
</div><p>MDT stock opened at $76.12 on Friday. The company has a market capitalization of $97.73 billion, a P/E ratio of 21.20, a PEG ratio of 1.83 and a beta of 0.62. Medtronic PLC has a twelve month low of $74.40 and a twelve month high of $106.33. The business has a 50 day simple moving average of $84.76 and a 200-day simple moving average of $93.64. The company has a current ratio of 2.54, a quick ratio of 1.87 and a debt-to-equity ratio of 0.57.</p>
<div class="lb-trans"><p>MDT 股票在周五开盘价为 76.12 美元。该公司的市值为 977.3 亿美元，市盈率为 21.20，市盈增长比率为 1.83，贝塔值为 0.62。Medtronic PLC 的 12 个月低点为 74.40 美元，12 个月高点为 106.33 美元。该公司的 50 日简单移动平均线为 84.76 美元，200 日简单移动平均线为 93.64 美元。该公司的流动比率为 2.54，速动比率为 1.87，债务与股本比率为 0.57。</p>
</div><ul>
<li>Intuitive Surgical's Selloff Sets Up a 30% Rebound Opportunity</li>
</ul>
<div class="lb-trans"><ul>
<li>Intuitive Surgical 的抛售为 30% 的反弹机会铺平道路</li>
</ul>
</div><p>Medtronic (NYSE:MDT - Get Free Report) last released its quarterly earnings results on Tuesday, February 17th. The medical technology company reported $1.36 EPS for the quarter, topping the consensus estimate of $1.34 by $0.02. Medtronic had a return on equity of 14.82% and a net margin of 13.00%.The business had revenue of $9.02 billion during the quarter, compared to analysts' expectations of $8.89 billion. During the same quarter in the prior year, the business earned $1.38 earnings per share. The company's quarterly revenue was up 5.8% compared to the same quarter last year. Medtronic has set its FY 2026 guidance at 5.620-5.660 EPS. As a group, equities analysts anticipate that Medtronic PLC will post 5.57 EPS for the current year.</p>
<div class="lb-trans"><p>Medtronic（纽约证券交易所代码：MDT - 获取免费报告）最近于 2 月 17 日星期二发布了季度财报。这家医疗技术公司报告本季度每股收益为 1.36 美元，超出市场共识预期的 1.34 美元 0.02 美元。Medtronic 的股本回报率为 14.82%，净利润率为 13.00%。该公司本季度的收入为 90.2 亿美元，而分析师预期为 88.9 亿美元。在去年同期，该公司每股收益为 1.38 美元。与去年同期相比，该公司的季度收入增长了 5.8%。Medtronic 将其 2026 财年的指引设定为每股收益 5.620-5.660。整体来看，股票分析师预计 Medtronic PLC 今年将发布每股收益 5.57。</p>
</div><h2>Medtronic Announces Dividend</h2>
<div class="lb-trans"><h2>Medtronic 宣布分红</h2>
</div><p>The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 17th. Shareholders of record on Friday, March 27th were given a $0.71 dividend. The ex-dividend date was Friday, March 27th. This represents a $2.84 annualized dividend and a yield of 3.7%. Medtronic's dividend payout ratio is presently 79.11%.</p>
<div class="lb-trans"><p>该公司还最近披露了季度分红，已于 4 月 17 日星期五支付。3 月 27 日的股东获得了 0.71 美元的分红。除息日期为 3 月 27 日。这代表着每年 2.84 美元的分红，收益率为 3.7%。Medtronic 的分红支付比率目前为 79.11%。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师升级和降级</h2>
</div><ul>
<li>5 Spin-Off Stocks That Could Reward Patient Investors in 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>5 只可能在 2026 年回报耐心投资者的分拆股票</li>
</ul>
</div><p>Several analysts recently issued reports on the stock. JPMorgan Chase &amp; Co. reduced their price objective on shares of Medtronic from $105.00 to $100.00 and set a &#34;neutral&#34; rating on the stock in a report on Wednesday, February 18th. Weiss Ratings lowered shares of Medtronic from a &#34;buy (b-)&#34; rating to a &#34;hold (c+)&#34; rating in a research note on Tuesday, April 21st. Jefferies Financial Group reiterated a &#34;hold&#34; rating and set a $95.00 price target on shares of Medtronic in a research note on Thursday, April 23rd. Needham &amp; Company LLC reiterated a &#34;buy&#34; rating and set a $120.00 price target on shares of Medtronic in a research note on Thursday, March 26th. Finally, CICC Research initiated coverage on shares of Medtronic in a research note on Friday, January 30th. They set an &#34;outperform&#34; rating on the stock. Fifteen investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to MarketBeat, the stock has an average rating of &#34;Moderate Buy&#34; and an average price target of $107.80.</p>
<div class="lb-trans"><p>几位分析师最近对该股票发布了报告。摩根大通将 Medtronic 的目标价从 105.00 美元下调至 100.00 美元，并在 2 月 18 日的报告中对该股票给予了 “中性” 评级。Weiss Ratings 将 Medtronic 的评级从 “买入（b-）” 下调至 “持有（c+）”，在 4 月 21 日的研究报告中。Jefferies Financial Group 重申了 “持有” 评级，并在 4 月 23 日的研究报告中将 Medtronic 的目标价设定为 95.00 美元。Needham &amp; Company LLC 重申了 “买入” 评级，并在 3 月 26 日的研究报告中将 Medtronic 的目标价设定为 120.00 美元。最后，中金公司在 1 月 30 日的研究报告中对 Medtronic 开展了覆盖，给予了该股票 “跑赢大盘” 的评级。十五位投资分析师对该股票给予了买入评级，十一位给予了持有评级。根据 MarketBeat，该股票的平均评级为 “适度买入”，平均目标价为 107.80 美元。</p>
</div><p><strong>View Our Latest Analysis on MDT</strong></p>
<div class="lb-trans"><p><strong>查看我们对 MDT 的最新分析</strong></p>
</div><h2>Insider Transactions at Medtronic</h2>
<div class="lb-trans"><h2>Medtronic 的内部交易</h2>
</div><p>In other Medtronic news, EVP Harry Skip Kiil sold 52,524 shares of the company's stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $97.71, for a total value of $5,132,120.04. Following the sale, the executive vice president owned 32,768 shares of the company's stock, valued at approximately $3,201,761.28. This represents a 61.58% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which is accessible through the SEC website. Insiders own 0.26% of the company's stock.</p>
<div class="lb-trans"><p>在其他 Medtronic 的新闻中，执行副总裁 Harry Skip Kiil 于 2 月 19 日星期四出售了 52,524 股该公司的股票。股票以平均价格 97.71 美元出售，总价值为 5,132,120.04 美元。出售后，该执行副总裁持有 32,768 股该公司的股票，价值约为 3,201,761.28 美元。这代表着他们持有的股票减少了 61.58%。该交易已在向证券交易委员会提交的文件中披露，文件可通过 SEC 网站访问。内部人士持有该公司 0.26% 的股票。</p>
</div><h2>Medtronic Company Profile</h2>
<div class="lb-trans"><h2>Medtronic 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Medtronic plc is a global medical technology company that develops and manufactures a broad range of therapeutic devices and health care solutions. Headquartered legally in Ireland with principal operational offices in the United States, the company markets products to hospitals, physicians and health systems worldwide and has grown from its founding in 1949 into one of the largest medical-device manufacturers serving global health-care markets.</p>
<div class="lb-trans"><p>Medtronic plc 是一家全球医疗技术公司，开发和制造广泛的治疗设备和医疗保健解决方案。公司合法总部位于爱尔兰，主要运营办公室位于美国，向全球医院、医生和医疗系统销售产品，自 1949 年成立以来，已发展成为服务全球医疗市场的最大医疗设备制造商之一。</p>
</div><p>Medtronic's offerings span several clinical areas, including cardiac rhythm and heart failure (pacemakers, implantable cardioverter‑defibrillators and related cardiac therapies), minimally invasive and surgical technologies (laparoscopic and advanced energy devices, visualization systems and surgical innovations), restorative therapies (spine and orthopedics, neuromodulation and neurovascular treatments) and diabetes management (insulin-delivery systems and glucose monitoring solutions).</p>
<div class="lb-trans"><p>美敦力的产品涵盖多个临床领域，包括心脏节律和心力衰竭（心脏起搏器、植入式心脏复律除颤器及相关心脏治疗）、微创和外科技术（腹腔镜和先进能量设备、可视化系统及外科创新）、修复治疗（脊柱和骨科、神经调节和神经血管治疗）以及糖尿病管理（胰岛素输送系统和血糖监测解决方案）。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Medtronic</li>
<li>Viking Sails to All-Time Highs—Fundamentals Signal More to Come</li>
<li>Datavalut Gains Traction: 5 Reasons to Sell Now</li>
<li>TMC Stock: Why This Pre-Revenue Miner Is Worth Watching</li>
<li>The Power Grid Is Dying—Is It Time to Buy Its Replacement?</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比美敦力更好的股票</li>
<li>维京航运创下历史新高——基本面信号显示未来还有更多</li>
<li>Datavalut 获得关注：现在卖出的五个理由</li>
<li>TMC 股票：为什么这家无收入矿业公司值得关注</li>
<li>电网正在衰退——是时候购买其替代品了吗？</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding MDT?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic PLC (NYSE:MDT - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对美敦力持有股份的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取美敦力 PLC（NYSE:MDT - 免费报告）的最新 13F 文件和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=MDT"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Medtronic Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在美敦力吗？</h2>
</div><p>Before you consider Medtronic, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑美敦力之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medtronic wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而美敦力并不在名单上。</p>
</div><p>While Medtronic currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然美敦力目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Arbejdsmarkedets Tillaegspension Makes New Investment in Medtronic PLC $MDT

Market Beat

纽交所高增长板生物技术指数 ETF - First Trust

2 倍做多纳斯达克生物技术 ETF - ProShares

纳斯达克生物科技指数 ETF - iShares Nasdaq

生物科技 ETF - VanEck Vectors

动态生物技术与基因组 ETF - Invesco

标普生物技术 ETF - SPDR

标普生物技术 3 倍做多 - Direxion

标普健康医疗设备 ETF - SPDR

直觉外科

摩根大通

Jefferies Financial

中金公司

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

Arbejdsmarkedets Tillaegspension 对美敦力 PLC $MDT 进行了新的投资